GC-2 - Central Laboratory Solutions for Pharmaceutical Research and Development bi13282034 Precise, continually updated information an essential element of the efficiency of the best products and services

China?s Allure Drug Research bi13282034 A pledge by Merck to invest $1.5 billion research and development China suggests that the industry?s center of gravity shifting eastward

Research and Markets: Triple Analysis: Leukemia, Lymphoma and Peptides bi13282034 DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/cdaaf8/triple_analysis_l) has announced the addition of the "Triple Analysis: Leukemia, Lymphoma and Peptides" report to offering. This triple analysis focuses on cancer drug development strategies both Leukemia and Lymphoma and by the compound strategy of Peptides. Each of these three individual ..

Research and Markets: Triple Analysis: Colorectal Cancer, Lymphoma and Peptides bi13282034 DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/434b62/triple_analysis_c) has announced the addition of the "Triple Analysis: Colorectal Cancer, Lymphoma and Peptides" report to offering. This triple analysis focuses on cancer drug development strategies both Colorectal Cancer and Lymphoma and by the compound strategy of Peptides. Each of ..

Research and Markets: IMS Pharmaceutical Pricing & Reimbursement Concise Guid bi13282034 DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/fa230f/ims_) has announced the addition of the "IMS Pricing & Reimbursement Concise Guide: Finland" report to offering. The Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around ..

Nuvo Research to increase ownership Nuvo Research AG to 100 percent bi13282034 MISSISSAUGA, ON, Dec. 5, 2011 /PRNewswire/ - Nuvo Research Inc. (TSX: NRI), a specialty company dedicated to building a portfolio of products for the topical treatment of pain and the development of immune modulating drug candidate WF10, today announced has..

UK to push new medicines and open up NHS data bi13282034 LONDON (Reuters) - Britain said Monday would promote use of new medicines and use a 180 million pounds ($280 million) fund to bring modern technologies to market under a package of reforms designed to attract investment from big s companies. Prime Minister David Cameron also outlined plans to open up a potential treasure trove of anonymized medical data collected by the state ..

Pharmaceutical Head Sees Ongoing Risk to Market From Crisis bi13282034 The growth of the domestic industry might decline next year the situation Europe and the United States, are struggling to fight a sovereign debt crisis, deteriorates, an international drug maker said Tuesday

Research and Markets: Romania Pharmaceutical Report 2011: Market Data, Produc bi13282034 DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/d1331e/intellinews_romani) has announced the addition of the "IntelliNews Romania Report 2011" report to offering. IntelliNews' Romania Report 2011 reviews manufacturers and distributors, gives market share and contact details of the industry's players - both national ..

Research and Markets: IMS Pharmaceutical Pricing & Reimbursement Concise Guid bi13282034 DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/6254fc/ims_) has announced the addition of the "IMS Pricing & Reimbursement Concise Guide: Denmark" report to offering. The Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around ..

Research and Markets: IMS Pharmaceutical Country Review: Australia 2011 bi13282034 DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/3e77e2/ims_country_review) has announced the addition of the "IMS Country Review: Australia" report to offering. Country Reviews provides comprehensive qualitative insights a specific market as well as showing sales trends over the last 5 years. Sales performance analysed ..

Research and Markets: IMS Pharmaceutical Pricing & Reimbursement Concise Guid bi13282034 DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/fa230f/ims_) has announced the addition of the "IMS Pricing & Reimbursement Concise Guide: Finland" report to offering. The Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around ..

Research and Markets: IMS Pharmaceutical Pricing & Reimbursement Concise Guid bi13282034 DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/de8e4c/ims_) has announced the addition of the "IMS Pricing & Reimbursement Concise Guide: Hungary" report to offering. The Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around ..

Ps2 Backup Software - Home